全文获取类型
收费全文 | 10087篇 |
免费 | 1065篇 |
国内免费 | 242篇 |
专业分类
耳鼻咽喉 | 68篇 |
儿科学 | 238篇 |
妇产科学 | 172篇 |
基础医学 | 1210篇 |
口腔科学 | 310篇 |
临床医学 | 937篇 |
内科学 | 877篇 |
皮肤病学 | 520篇 |
神经病学 | 286篇 |
特种医学 | 380篇 |
外国民族医学 | 13篇 |
外科学 | 981篇 |
综合类 | 1648篇 |
现状与发展 | 2篇 |
预防医学 | 326篇 |
眼科学 | 193篇 |
药学 | 503篇 |
13篇 | |
中国医学 | 323篇 |
肿瘤学 | 2394篇 |
出版年
2024年 | 18篇 |
2023年 | 132篇 |
2022年 | 211篇 |
2021年 | 376篇 |
2020年 | 369篇 |
2019年 | 299篇 |
2018年 | 303篇 |
2017年 | 345篇 |
2016年 | 400篇 |
2015年 | 398篇 |
2014年 | 587篇 |
2013年 | 639篇 |
2012年 | 486篇 |
2011年 | 581篇 |
2010年 | 424篇 |
2009年 | 400篇 |
2008年 | 427篇 |
2007年 | 434篇 |
2006年 | 425篇 |
2005年 | 404篇 |
2004年 | 355篇 |
2003年 | 330篇 |
2002年 | 291篇 |
2001年 | 278篇 |
2000年 | 236篇 |
1999年 | 213篇 |
1998年 | 201篇 |
1997年 | 189篇 |
1996年 | 181篇 |
1995年 | 166篇 |
1994年 | 153篇 |
1993年 | 127篇 |
1992年 | 125篇 |
1991年 | 140篇 |
1990年 | 98篇 |
1989年 | 94篇 |
1988年 | 71篇 |
1987年 | 63篇 |
1986年 | 61篇 |
1985年 | 55篇 |
1984年 | 56篇 |
1983年 | 48篇 |
1982年 | 42篇 |
1981年 | 36篇 |
1980年 | 40篇 |
1979年 | 22篇 |
1978年 | 16篇 |
1977年 | 21篇 |
1976年 | 15篇 |
1975年 | 5篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
61.
自1977~1988年我院共收治13例原发睾丸恶性淋巴瘤,占同期睾丸恶性肿瘤的11.5%。本病少见,大部分发生在50岁以上。本文50岁以上者10例,约占80%。此病预后差,本文11侧2年内死亡,占85%。5年生存率仅为15%。本文5例术后辅以放、化疗,8例术后单纯化疗,两者生存期无明显差异,故我们认为手术 化疗为本病的首选治疗方案。 相似文献
62.
目的:观察EDOP方案治疗复发难治性恶性淋巴瘤的疗效和毒副作用。方法:对45例复发难治性恶性淋巴瘤患者采用EDOP联合化疗方案进行治疗。结果:EDOP联合化疗方案有效率为(CR+PR)71.1%,完全缓解率(CR)为33.3%,部分缓解(PR)37.8%。主要不良反应为骨髓抑制和胃肠道反应。结论:EDOP方案治疗难治性或复发性恶性淋巴瘤有效率高,毒副反应低,值得进一步研究和推广。 相似文献
63.
健脾疏肝利水法为主内外合治恶性腹腔积液 总被引:3,自引:0,他引:3
王莉珍 《上海中医药大学学报》2003,17(4):27-28
观察健脾疏肝利水为主的中医药内服外敷治疗恶性腹腔积液的疗效。设治疗组 3 8例采用内服中药加中药外敷腹部 ,配服西药利尿剂。对照组 2 7例 ,常规服西药利尿剂及对症治疗 ,疗程均为 1个月。结果 :治疗组有效率为65 7% ,对照组有效率为 48 1% (P <0 0 5 )。生存期 6个月以上、1年以上者 :治疗组分别为 12例、4例 ,对照组为 5例、0例。提示以中医药内外合治为主对恶性腹腔积液疗效明显高于单纯用西药利尿剂 相似文献
64.
在耳鼻咽喉科手术中应用颈外动脉栓塞法10例,形成栓塞组,并把单纯颈外动脉结扎10例作为对照组。结果表明:栓塞组较对照组术中出血量显著减少,有利于病灶彻底清除,因而有提高治愈率减少复发率的作用。掌握栓塞位置、栓塞剂用量和注射速度是防止并发症的关键。 相似文献
65.
A. Sil P. Chatrath N. Warwick-Brown 《Indian journal of otolaryngology and head and neck surgery》2004,56(1):59-62
Absract Malignant Melanoma of the nose is a rare neoplasm, with primary mucosal melanoma being more aggressive than its cutaneous
counterpart (Land,1982). The presentation is often not as dramatic as compared to its progression. While cutaneous melanomas
typically present with obvious and consistent features, melanomas of the mucosal form are often diagonised late due to their
hidden location and relatively non-specific features. This tumour can metasiasise by lymphasies or bloodsream. Moreover the
tumour is often quite resistent to complete cure especially due to reccurence and metastotis. We wish to empahsize that early
diagonisis with a high index of suspicion is essential for the management of this condition, by means of two case reports
of patients who attended the ENT clinic at Southend Hospital, UK, both of whom were being treated for nasal polyposis in whom
the diagonisis susbsequently turned out to be malignant melanoma. 相似文献
66.
Khalid Ahmed AL-ANAZI Asma Marzouq AL-JASSER David Alan Price EVANS Nasr Abu DAFF 《Asia-Pacific Journal of Clinical Oncology》2006,2(2):91-97
Background: Surgical intervention in patients with malignant hematological disorders is a major undertaking due to the expected risks of bleeding, infection and poor wound healing. Methods and materials: A retrospective study of patients treated at the Riyadh Armed Forces Hospital, Saudi Arabia between January 1991 and December 2002 was conducted. The results of patients with acute leukemia and lymphoma who underwent surgical procedures (study group) were compared with those of a control group composed of patients with the same spectrum of disorders treated over the same period of time and given the same treatment protocols but never required any surgery. Results: No single death occurred intraoperatively or in the immediate postoperative period due to surgical therapy per se. However, follow up of both groups of patients revealed a shorter long‐term survival and higher rates of relapse and severe invasive infections in the surgical group compared to the control group of patients. The mean survival for the study group was 1871 ± 307 days versus 3094 ± 279 days for the control group of patients (P = 0.0027). Thirty (75%) study patients suffered relapses of their malignant hematological disorders versus 23 (37.1%) control patients. Forty‐five relapses were encountered in the study group of patients (1.5 relapses per relapsed patient) versus 26 relapses in the control group (1.13 relapses per relapsed patient). Various infections occurred in 37 (92.5%) study patients and 32 (51.6%) control patients. Recurrent infections developed in 30 (75%) study patients and 22 (35.5%) control patients (P = 0.00008). Infections causing tissue invasion were encountered in 29 (72.5%) study patients and 22 (35.5%) control patients. Conclusion: Even major surgical procedures can be performed in patients with leukemia or lymphoma provided enough preparatory measures are made to minimize bleeding and infectious complications. Surgery may, however, be associated with long‐term complications such as a high incidence of relapse of the primary malignant hematological disorder and an increased rate of severe and invasive infections. 相似文献
67.
斯奇康联合丝裂霉素顺铂胸腔内注射治疗肺癌恶性胸水的疗效观察 总被引:2,自引:0,他引:2
目的 探讨斯奇康联合丝裂霉素、顺铂胸腔内注射治疗肺癌恶性胸水的有效性和安全性。方法 对我科1999年以来确诊为肺癌恶性胸水的 5 3例患者 ,随机分为斯奇康组 ( 2 7例 )和对照组 ( 2 6例 ) ,进行胸腔内注药 ,观察治疗的有效率、Karnofsky评分及不良反应。结果 斯奇康组与对照组治疗有效率分别为 88 8%和 5 3 9%,两组比较有显著性差异 (P <0 0 1) ;两组治疗后生存质量均有改善 ,但Karnofsky评分 70分以上治疗组为 66 7%,对照组为 3 0 8%,两组比较差异显著 (P <0 0 1) ;两组均出现不同程度的白细胞、血小板减少 ,但治疗组与对照组相比反应明显较轻 ,有显著性差异 (P <0 0 5 )。结论 斯奇康联合丝裂霉素、顺铂胸腔内注射治疗肺癌恶性胸水疗效较好 ,毒副反应较轻。 相似文献
68.
T Fikrle K Pizinger 《Journal of the European Academy of Dermatology and Venereology》2007,21(1):48-55
BACKGROUND: Digital computer analysis of dermatoscopical images has been reported to facilitate the differential diagnosis of pigmented skin lesions in recent years. OBJECTIVE: The aim of our study was to perform digital computer analysis of a set of different melanocytic lesions and compare the objective results. METHODS: The set of 260 melanocytic lesions (150 excised difficult cases (46 melanomas, 47 atypical nevi, 57 common nevi and 110 unexcised common nevi) was automatically analysed by the digital dermatoscopical system microDERM. We searched for differences in asymmetry, size, compactness and colour distribution. Perimeter/area ratio was calculated. RESULTS: The perimeter/area ratio was detected as the most important criterion for differentiation between malignant and benign melanocytic lesions (sensitivity 91.3% and specificity 90.7% for malignant melanomas vs. all benign nevi; sensitivity 91.3% and specificity 80.8% for melanomas vs. clinically atypical nevi). Differences in size of the lesion, shape and asymmetry of colour were found and statistically verified. Using step-wise logistic regression the formula for calculation of probability of malignant nature of every analysed lesion was constructed. CONCLUSION: The perimeter/area ratio is a simple parameter for the differential diagnosis of melanocytic skin lesions. 相似文献
69.
N.D. Stafford L.T. Condon M.J.C. Rogers A.W. MacDonald S.L. Atkin 《Clinical otolaryngology》2003,28(4):314-319
The expression of somatostatin receptors 1 and 2 in benign, pre‐malignant and malignant laryngeal lesions The role of chemotherapy in squamous cell carcinoma of the larynx has not been clearly defined. Whilst toxic chemotherapy regimes may confer a marginal improvement in survival, surgery and radiotherapy remain the mainstay of treatment. Somatostatin is a naturally occurring peptide, which exerts antiproliferative and antiangiogenic effects via five membrane‐bound receptor subtypes. The expression of somatostatin receptor subtypes (SSTRs) 1 and 2 was studied in benign, pre‐malignant and malignant laryngeal specimens. Epithelial expression of SSTR1 was detected in 4/6 (67%) Reinke's oedema, 5/6 (83%) pre‐malignant and 8/12 (67%) malignant specimens, with virtually no stromal or vascular expression. High levels of epithelial SSTR2 expression were noted in all Reinke's oedema specimens, compared with low‐to‐moderate levels in only 2/6 (33%) pre‐malignant and 3/12 (25%) malignant specimens (P < 0.01). This ‘loss’ of epithelial SSTR2 expression may provide a growth advantage in pre‐malignant and malignant laryngeal lesions. Vascular expression of SSTR2 was ubiquitous in all groups, with scant stromal expression. Overall, most (>80%) pre‐malignant and malignant laryngeal specimens expressed at least one of the two SSTR subtypes studied. Somatostatin analogues may have a therapeutic role in squamous cell carcinoma of the larynx. 相似文献
70.